Signal active
Investment Firm
Overview
CareDx is a molecular diagnostics company. They offer noninvasive surveillance tests to help identify injuries and rule out rejection. They deliver solutions that support a broad spectrum of needs, from initial matching to post-transplant monitoring and care.
Highlights
1998
Information Technology
501-1000
1
1
1
Late Stage Venture
N/A
Location
United States, North America
Contact Information
Social
Profile Resume
CareDx, established in 1998 and headquartered in United States, North America., specializes in Late Stage Venture investments across Biotechnology, Health Care, Medical, Medical Device. Their recent investments include Miromatrix Medical. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
1
1
1
1
Investments
1
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
May 28, 2021 | Miromatrix Medical | Biotechnology | null |
Exits
1
Funding Timeline
1
15
0
Funding Rounds
1
CareDx has raised 1 rounds. Their latest funding was raised on May 28, 2021 from a Series C - Miromatrix Medical round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
May 28, 2021 | Series C - Miromatrix Medical | - | 0 | - |
Investors
39
CareDx is funded by 39 investor(s). Armentum Partners and Silicon Valley Bank Kantor are the most recent investors.
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
- | No | Post-IPO Equity - CareDx | 18.3M |
- | No | Post-IPO Equity - CareDx | 52.8M |
- | No | Post-IPO Equity - CareDx | 117.1M |
- | No | Post-IPO Equity - CareDx | 164.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.